Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.42 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14930826 | 0.87 | NPC1 (0.42) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14924991 | 0.87 | NPC1 (0.56) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14924989 | 0.87 | SMN1; SMN2 (0.47) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14924985 | 0.83 | NPC1 (0.48) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14924932 | 0.81 | MAPT (0.51) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14029824 | 0.80 | POLB (0.40) | MAPK1MAPTHIF1AEPAS1POLB | |
| SCHEMBL14930825 | 0.75 | NPC1 (0.56) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14930821 | 0.75 | ALDH1A1 (0.47) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 | |
| SCHEMBL14048017 | 0.73 | L3MBTL1 (0.44) | SMN1; SMN2RAB9ANPC1LMNATSHR | |
| SCHEMBL14029845 | 0.72 | PTGER1 (0.47) | SMN1; SMN2RAB9ANPC1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130116252-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116431-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116251-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116253-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116252-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | SMN1; SMN2 4619/4885RAB9A 2218/4885NPC1 1521/4885 |
| US-20130116253-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | SMN1; SMN2 4619/4885RAB9A 2218/4885NPC1 1521/4885 |
| US-20130116251-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | SMN1; SMN2 4619/4885RAB9A 2218/4885NPC1 1521/4885 |
| US-20130116431-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | SMN1; SMN2 4619/4885RAB9A 2218/4885NPC1 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.